Ballentine Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $599K | Buy |
|
|||||
|
2025
Q2 | $505K | Sell |
|
|||||
|
2025
Q1 | $641K | Buy |
|
|||||
|
2024
Q4 | $653K | Sell |
|
|||||
|
2024
Q3 | $1.12M | Buy |
|
|||||
|
2024
Q2 | $1.06M | Sell |
|
|||||
|
2024
Q1 | $1M | Buy |
|
|||||
|
2023
Q4 | $663K | Sell |
|
|||||
|
2023
Q3 | $820K | Buy |
|
|||||
|
2023
Q2 | $512K | Sell |
|
|||||
|
2023
Q1 | $918K | Buy |
|
|||||
|
2022
Q4 | $559K | Buy |
|
|||||
|
2022
Q3 | $401K | Buy |
|
|||||
|
2022
Q2 | $206K | Sell |
|
|||||
|
2022
Q1 | $264K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $222K | Buy |
|
|||||
|
2016
Q1 | $225K | Buy |
|